Cutaneous melanoma susceptibility and progression genes.
about
Polymorphisms in the syntaxin 17 gene are not associated with human cutaneous malignant melanomaThe Pathophysiological Impact of HLA Class Ia and HLA-G Expression and Regulatory T Cells in Malignant Melanoma: A ReviewCapturing the biological impact of CDKN2A and MC1R genes as an early predisposing event in melanoma and non melanoma skin cancerVitamin D receptor gene polymorphisms, serum 25-hydroxyvitamin D levels, and melanoma: UK case-control comparisons and a meta-analysis of published VDR dataAssociation between melanocytic nevi and risk of breast diseases: The French E3N prospective cohort.Gene network analyses point to the importance of human tissue kallikreins in melanoma progressionMelanoma: clinical features and genomic insights.Genetics of familial melanoma: 20 years after CDKN2A.Joint effect of multiple common SNPs predicts melanoma susceptibilityMolecular characterization of melanoma cases in Denmark suspected of genetic predispositionPax genes in embryogenesis and oncogenesis.High- and low-penetrance cutaneous melanoma susceptibility genes.Pocket protein function in melanocyte homeostasis and neoplasia.Cutaneous melanoma in genetically modified animals.Gene expression profiling and clinical outcome in melanoma: in search of novel prognostic factors.Genetic determinants of cutaneous melanoma predisposition.Common sequence variants on 20q11.22 confer melanoma susceptibilityLack of inherited mutations of PTPRD in familial melanoma and melanoma-astrocytoma syndrome.Towards new therapeutic approaches for malignant melanoma.Reviewing the somatic genetics of melanoma: from current to future analytical approaches.Melanocytic nevi and melanoma: unraveling a complex relationship.Inhibition of CXCR4-CXCL12 chemotaxis in melanoma by AMD11070.Multiple melanoma susceptibility factors function in an ultraviolet radiation response pathway in skin.EGFR in melanoma: clinical significance and potential therapeutic target.Two cases of uveal amelanotic melanoma in transgenic Tyr-HRAS+ Ink4a/Arf heterozygous mice.Multiparameter analysis of naevi and primary melanomas identifies a subset of naevi with elevated markers of transformation.Prevalence of Germline BAP1, CDKN2A, and CDK4 Mutations in an Australian Population-Based Sample of Cutaneous Melanoma Cases.Hereditary melanoma: a five-year study of Brazilian patients in a cancer referral center - phenotypic characteristics of probands and pathological features of primary tumors.
P2860
Q24619042-3984A85A-8A24-4DEB-891C-D07CE0B2064EQ28080338-6A9239F5-113B-4369-A4D1-D2C4BFD26322Q28238393-C5DAF7D0-0A4A-4F91-89A9-54B578185C61Q33483893-940E8548-5167-44E5-B85F-477221DCBC4FQ33733935-71FB7F98-6028-419B-BE46-CD6FA92A08C1Q34060071-F001DDD4-6945-40B6-B99A-266EA90548C3Q34083191-1E1161E7-FFAE-427D-8632-F48EA99C4E35Q34449957-3C48C6C6-3368-49E3-B923-A08BCD1F741DQ35083167-96C11D74-138A-4782-B217-6EFE081B166AQ35213835-65BB304E-B50B-4822-B72E-4CEB76251615Q35886629-9F5FADB6-0C28-4938-A220-4F7CF140B7C9Q36499211-3B42EEA3-2A61-494D-AF64-9981C45FD132Q36530303-935F811C-B1B6-49AF-9B5E-292883E6DE2CQ36970648-DE4D1F41-74AC-4606-B1ED-1ACB97743BBDQ37004685-C9CFA160-E84C-453A-BC96-09500F037359Q37137000-5E9BAA08-FCF8-4D12-A3B4-792B741C73C8Q37371151-77B1413A-A073-4935-8C1D-F5D9ED4C818AQ37377962-EE377926-2D50-4780-94E3-80C1F1C082FDQ37951743-457FF69B-16F3-4490-BC85-B1988E32DA38Q37976140-A34962A8-627E-4D45-9C90-D07B75856FBFQ38730348-EDAEAC1F-5260-42FE-B775-9F48FD13556AQ39174058-4E6B3012-725D-434A-A538-98388D7B53EBQ39472778-133C093A-430A-4F16-8C6E-B4E002CBD8BCQ39586032-F890589F-810E-4D24-B2C3-A7BD16062E0FQ46911362-175CB23F-464C-4FD4-93B7-F6C1CBA33A34Q53103604-FAC28CCC-305D-41C1-BF2F-0E8B0385135DQ55063850-06ED50E6-47C2-4805-B315-CEC49986C3C1Q55344486-5299C3D3-ED28-4205-B9D6-6EF408D83649
P2860
Cutaneous melanoma susceptibility and progression genes.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Cutaneous melanoma susceptibility and progression genes.
@ast
Cutaneous melanoma susceptibility and progression genes.
@en
type
label
Cutaneous melanoma susceptibility and progression genes.
@ast
Cutaneous melanoma susceptibility and progression genes.
@en
prefLabel
Cutaneous melanoma susceptibility and progression genes.
@ast
Cutaneous melanoma susceptibility and progression genes.
@en
P1433
P1476
Cutaneous melanoma susceptibility and progression genes.
@en
P2093
Femke A de Snoo
Nicholas K Hayward
P304
P356
10.1016/J.CANLET.2004.12.033
P407
P577
2005-12-01T00:00:00Z